Secondary Prophylaxis Gastric Variceal Bleed

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Cirrhosis
Interventions
PROCEDURE

Endoscopic Cyanoacrylate injection

Endoscopic Cyanoacrylate injection in gastric varix

DRUG

beta-blocker (propranolol)

Propranolol was started at a dose of 20 mg twice daily. The principle of incremental dosing was used to achieve the target heart rate for propranolol. The dose was increased every alternate day to achieve a target heart rate of 55/min or to the maximal dose to 360 mg/day if the medication was well tolerated and the systolic blood pressure was \>90 mm Hg. On the occurrence of intolerable adverse effects, systolic blood pressure \<90 mm Hg or pulse rate \<55/min, the dose of the medication was decreased step-wise, and eventually stopped if these adverse events persisted. Reintroduction of the medication was attempted if cessation of the medication did not result in improvement of the reported side-effect.

Trial Locations (1)

110002

G B Pant Hospital, New Delhi

All Listed Sponsors
lead

Govind Ballabh Pant Hospital

OTHER_GOV

NCT00888784 - Secondary Prophylaxis Gastric Variceal Bleed | Biotech Hunter | Biotech Hunter